| Literature DB >> 26618092 |
Victoria Suarez-Ulloa1, Juan Fernandez-Tajes2, Vanessa Aguiar-Pulido3, M Veronica Prego-Faraldo4, Fernanda Florez-Barros5, Alexia Sexto-Iglesias6, Josefina Mendez6, Jose M Eirin-Lopez1.
Abstract
Background. Harmful Algal Blooms (HABs) responsible for Diarrhetic Shellfish Poisoning (DSP) represent a major threat for human consumers of shellfish. The biotoxin Okadaic Acid (OA), a well-known phosphatase inhibitor and tumor promoter, is the primary cause of acute DSP intoxications. Although several studies have described the molecular effects of high OA concentrations on sentinel organisms (e.g., bivalve molluscs), the effect of prolonged exposures to low (sublethal) OA concentrations is still unknown. In order to fill this gap, this work combines Next-Generation sequencing and custom-made microarray technologies to develop an unbiased characterization of the transcriptomic response of mussels during early stages of a DSP bloom. Methods. Mussel specimens were exposed to a HAB episode simulating an early stage DSP bloom (200 cells/L of the dinoflagellate Prorocentrum lima for 24 h). The unbiased characterization of the transcriptomic responses triggered by OA was carried out using two complementary methods of cDNA library preparation: normalized and Suppression Subtractive Hybridization (SSH). Libraries were sequenced and read datasets were mapped to Gene Ontology and KEGG databases. A custom-made oligonucleotide microarray was developed based on these data, completing the expression analysis of digestive gland and gill tissues. Results. Our findings show that exposure to sublethal concentrations of OA is enough to induce gene expression modifications in the mussel Mytilus. Transcriptomic analyses revealed an increase in proteasomal activity, molecular transport, cell cycle regulation, energy production and immune activity in mussels. Oppositely, a number of transcripts hypothesized to be responsive to OA (notably the Serine/Threonine phosphatases PP1 and PP2A) failed to show substantial modifications. Both digestive gland and gill tissues responded similarly to OA, although expression modifications were more dramatic in the former, supporting the choice of this tissue for future biomonitoring studies. Discussion. Exposure to OA concentrations within legal limits for safe consumption of shellfish is enough to disrupt important cellular processes in mussels, eliciting sharp transcriptional changes as a result. By combining the study of cDNA libraries and a custom-made OA-specific microarray, our work provides a comprehensive characterization of the OA-specific transcriptome, improving the accuracy of the analysis of expresion profiles compared to single-replicated RNA-seq methods. The combination of our data with related studies helps understanding the molecular mechanisms underlying molecular responses to DSP episodes in marine organisms, providing useful information to develop a new generation of tools for the monitoring of OA pollution.Entities:
Keywords: Biomonitoring; Diarrhetic shellfish poisoning; Harmful algal blooms; Marine pollution; Microarray; Okadaic acid; Transcriptomics
Year: 2015 PMID: 26618092 PMCID: PMC4655091 DOI: 10.7717/peerj.1429
Source DB: PubMed Journal: PeerJ ISSN: 2167-8359 Impact factor: 2.984
Reads and annotated contigs obtained from the cDNA libraries constructed.
| Normalized libraries | SSH libraries | |||
|---|---|---|---|---|
| Exposed | Control | Forward | Reverse | |
| Reads | 514,276 | 404,901 | 469,795 | 752,133 |
| Contigs | 24,624 | 16,395 | 21,591 | 33,437 |
| Annotated contigs | 10,617 (43%) | 7,335 (45%) | 6,448 (30%) | 18,553 (55%) |
Figure 1Venn diagram showing the extent of redundancy between the different libraries constructed in the present work: norm_ mgc, normalized control library; norm_mgt, normalized exposed library; ssh_fwd, SSH forward library; ssh_rev, SSH reverse library.
Figure 2V-plots showing gene expression differences detected through microarray analysis in digestive gland (A) and gill (B) tissues.
These differences are represented as net expression change (logFC) with statistical significance (FDR) indicated as a logarithmic scale. Probes highlighted in blue (FDR < 0.05) and purple (FDR < 0.05 and logFC > 2) represent the groups of transcripts displaying largest changes in gene expression between exposed and control treatments.
Figure 3Correlation between paired logFC values calculated for transcripts identified in digestive gland and gill tissues between exposed and control treatments.
Overall, a good level of agreement is found for gene expression changes (R2 ≅ 0.6).
Selected subsets of differentially expressed transcripts identified by microarray analysis representative of the following functional categories: (a) protein repair or degradation, (b) immune response, (c) transport and energy production and (d) cell cycle regulation.
|
|
|
| Heat shock 70 kda protein 12b | Mytimacin-5 |
| Cathepsin d | c1q domain-containing protein 1q3 |
| Cathepsin b | c1q domain-containing protein 1q25 |
| Proteasome subunit beta type-4 | Mytimicin precursor |
|
|
|
| Nose resistant to fluoxetine protein 6 | bcl2 adenovirus e1b 19-kd protein-interacting |
| Interferon-inducible GTPase 5-like | Apoptosis inhibitor iap |
| nadh dehydrogenase subunit | jagged 1 |
| Atpase H + transporting lysosomal 21 kda v0 subunit | Oncoprotein-induced transcript 3 protein |
Figure 4Graphical representation of the GO terms (general sub-categories in Biological Process ontology) most represented in transcripts differentially expressed for each mussel tissue according to the microarray analysis.
The length of the bars is proportional to the number of sequences annotated for each specific GO term.
Enriched GO terms in sets of differentially expressed transcripts in both digestive gland and gill tissues. Data is sorted based on p-value in increasing (p-values are calculated according to the weight algorithm in TopGO).
| GO term description | GO number | Annotated | Expected | |
|---|---|---|---|---|
|
| ||||
| Vesicle-mediated transport |
| 176 | 60.79 | 1.00E–09 |
| Maintenance of protein localization in endoplasmic reticulum |
| 16 | 5.53 | 3.80E–08 |
| Cellular response to glucose starvation |
| 19 | 6.56 | 5.70E–08 |
| Cellular modified amino acid metabolic process |
| 72 | 24.87 | 7.40E–08 |
| ER overload response |
| 15 | 5.18 | 1.10E–07 |
| Activation of signaling protein activity involved in unfolded protein response |
| 15 | 5.18 | 1.10E–07 |
| Cerebellum structural organization |
| 15 | 5.18 | 1.10E–07 |
| Regulation of cell migration |
| 47 | 16.23 | 2.40E–06 |
| Negative regulation of cellular response to growth factor stimulus |
| 23 | 7.94 | 2.80E–06 |
| Endosomal transport |
| 31 | 10.71 | 7.00E–06 |
| Pteridine-containing compound metabolic process |
| 17 | 5.87 | 7.00E–06 |
| Secretion by cell |
| 58 | 20.03 | 1.50E–05 |
| Coenzyme metabolic process |
| 117 | 40.41 | 1.70E–05 |
| Regulation of actin filament polymerization |
| 25 | 8.63 | 2.60E–05 |
| Cerebellar Purkinje cell layer development |
| 18 | 6.22 | 2.90E–05 |
| Cellular response to interleukin-4 |
| 27 | 9.33 | 3.00E–05 |
| Regulation of protein ubiquitination |
| 68 | 23.49 | 4.40E–05 |
| Negative regulation of protein polymerization |
| 15 | 5.18 | 4.60E–05 |
| Aminoglycan metabolic process |
| 29 | 10.02 | 0.00015 |
| Regulation of lipid metabolic process |
| 16 | 5.53 | 0.00017 |
|
| ||||
| DNA metabolic process |
| 157 | 102.77 | 2.60E–09 |
| Ribonucleoprotein complex biogenesis |
| 130 | 85.1 | 4.20E–08 |
| mRNA processing |
| 70 | 45.82 | 1.80E–06 |
| Cilium morphogenesis |
| 53 | 34.69 | 4.10E–06 |
| Transcription from RNA polymerase II promoter |
| 186 | 121.76 | 4.90E–06 |
| Mitochondrial ATP synthesis coupled electron transport |
| 81 | 53.02 | 1.50E–05 |
| Mitotic nuclear division |
| 82 | 53.68 | 2.30E–05 |
| Inorganic cation transmembrane transport |
| 109 | 71.35 | 2.80E–05 |
| Chromosome organization |
| 167 | 109.32 | 7.20E–05 |
| Microtubule-based movement |
| 97 | 63.5 | 8.20E–05 |
| Cilium organization |
| 42 | 27.49 | 0.00018 |
| Positive regulation of ubiquitin-protein transferase activity |
| 32 | 20.95 | 0.00019 |
| Sodium ion transport |
| 46 | 30.11 | 0.00022 |
| Anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process |
| 31 | 20.29 | 0.00028 |
| G1/S transition of mitotic cell cycle |
| 44 | 28.8 | 0.00029 |
| Mitotic S phase |
| 30 | 19.64 | 0.0004 |
| Chromatin remodeling |
| 39 | 25.53 | 0.0005 |
| Regulation of multi-organism process |
| 43 | 28.15 | 0.00058 |
| Cilium or flagellum-dependent cell motility |
| 17 | 11.13 | 0.00073 |
| Histone acetylation |
| 33 | 21.6 | 0.00078 |
|
| ||||
| Biological process |
| 926 | 516.95 | 1.60E–06 |
| Positive regulation of cell growth |
| 12 | 6.7 | 0.00087 |
| Carbohydrate metabolic process |
| 39 | 21.77 | 0.00149 |
| Cellular catabolic process |
| 30 | 16.75 | 0.04401 |
| Protein folding |
| 23 | 12.84 | 0.05753 |
| Protein polyubiquitination |
| 17 | 9.49 | 0.06629 |
| Lipid metabolic process |
| 24 | 13.4 | 0.09686 |
| Intracellular transport |
| 18 | 10.05 | 0.11899 |
| Nucleobase-containing compound catabolic process |
| 12 | 6.7 | 0.14577 |
| Proteolysis |
| 22 | 12.28 | 0.16789 |
| Single-organism developmental process |
| 94 | 52.48 | 0.19993 |
| Cellular macromolecular complex assembly |
| 11 | 6.14 | 0.20518 |
| Protein complex subunit organization |
| 11 | 6.14 | 0.20518 |
| Generation of neurons |
| 16 | 8.93 | 0.21463 |
| Vesicle-mediated transport |
| 21 | 11.72 | 0.21627 |
| Response to oxygen-containing compound |
| 10 | 5.58 | 0.28271 |
| Protein complex assembly |
| 10 | 5.58 | 0.31076 |
| Cell cycle |
| 17 | 9.49 | 0.31266 |
| Response to external stimulus |
| 17 | 9.49 | 0.31266 |
| Positive regulation of transcription, DNA-templated |
| 12 | 6.7 | 0.32401 |
|
| ||||
| Microtubule-based process |
| 25 | 7.31 | 1.40E–07 |
| Energy derivation by oxidation of organic compounds |
| 10 | 2.92 | 0.0012 |
| Heterocycle biosynthetic process |
| 35 | 10.23 | 0.0041 |
| Aromatic compound biosynthetic process |
| 35 | 10.23 | 0.0041 |
| Cellular nitrogen compound biosynthetic process |
| 37 | 10.82 | 0.0086 |
| Organic cyclic compound biosynthetic process |
| 38 | 11.11 | 0.0121 |
| Biological process |
| 926 | 270.74 | 0.0161 |
| Regulation of signal transduction |
| 18 | 5.26 | 0.0165 |
| Cellular protein modification process |
| 57 | 16.67 | 0.0537 |
| Nucleotide metabolic process |
| 11 | 3.22 | 0.0687 |
| Response to organic substance |
| 26 | 7.6 | 0.1048 |
| Single-organism transport |
| 66 | 19.3 | 0.1202 |
| Cell morphogenesis involved in differentiation |
| 10 | 2.92 | 0.1363 |
| Regulation of multicellular organismal process |
| 10 | 2.92 | 0.1363 |
| Purine-containing compound metabolic process |
| 10 | 2.92 | 0.1363 |
| Single-organism biosynthetic process |
| 19 | 5.56 | 0.1603 |
| Cell surface receptor signaling pathway |
| 31 | 9.06 | 0.1635 |
| Regulation of biological quality |
| 17 | 4.97 | 0.202 |
| Anatomical structure morphogenesis |
| 33 | 9.65 | 0.2438 |
| Protein modification by small protein conjugation |
| 28 | 8.19 | 0.2836 |